NIH-funded study shows sorafenib improves progression-free survival for patients with rare sarcomas | National Institutes of Health (NIH)

NIH-funded study shows sorafenib improves progression-free survival for patients with rare sarcomas | National Institutes of Health (NIH)

New on the MedlinePlus Cancer page:

NIH-Funded Study Shows Sorafenib Improves Progression-Free Survival for Patients With Rare Sarcomas

03/29/2018 03:55 PM EDT

Source: National Cancer Institute -